GRG's Center For Experiential Learning

Cancer treatment has come a long way from the days of one-size-fits-all chemotherapy and radiation. The era of personalized medicine has...

Cancer care has undergone a paradigm shift over the past decade, moving from generalized treatments to highly personalized therapies. At...

Cancer immunotherapy has transformed the way we approach cancer treatment by harnessing the body's immune system to fight the disease....

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma, accounting for approximately 30% of all cases....

The COVID-19 pandemic brought about many challenges, but it also catalyzed remarkable advancements in science and medicine. One of the...

Nuclear medicine, a potent tool for diagnosing and treating diseases, particularly in oncology, significantly impacts patient care. Its...

Nanomedicine, a branch of nanotechnology , is not just revolutionizing healthcare but also instilling hope for a future where diseases...

Radiation oncology stands at the intersection of art and science, where precision, technology, and profound human compassion converge to...

A groundbreaking innovation has emerged in cancer treatment, promising new hope for patients facing difficult-to-treat malignancies. Once...

Cancer remains one of the most formidable health challenges worldwide, but advancements in immunotherapy are turning the tide against...

The fight against cancer is a constant race for innovation. Monoclonal antibodies (mAbs) have emerged as powerful tools in this battle,...

Cancer, a formidable foe, has long challenged traditional treatment approaches. But a revolutionary therapy known as CAR-T (Chimeric...

Immunotherapy has revolutionized cancer treatment, harnessing the body's own immune system to fight tumors. But determining treatment...

For centuries, diseases caused by faulty genes have cast a long shadow over human health. But on the horizon, a groundbreaking medical...

In healthcare, few battles are as critical as the fight against cancer. With each passing day, researchers and medical professionals are...

In the rapidly advancing world of biotechnology, bionanoparticles are making waves. These minuscule particles, derived from biological...

The development : In October 2022, Dostarlimab met its primary endpoint of Objective Response Rate (ORR) in a head-to-head trial against...